<DOC>
	<DOC>NCT00666536</DOC>
	<brief_summary>The purpose of this trial is to compare blood pressure lowering efficacy of moderate Valsartan + Amlodipine treatment regimen (160 / 5 mg) with that of aggressive regimen (320 / 10 mg) in patients uncontrolled on ARB monotherapy, other than Valsartan</brief_summary>
	<brief_title>The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Amlodipine, Valsartan Drug Combination</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>Male and female outpatients 18 Years of age or older Mean Sitting Systolic Blood Pressure (the top number) greater than or equal to 150 mmHg and lower than 200 mmHg while on AngiotensinReceptor Blocker monotherapy for a minimum period of 28 days prior to randomization Mean Sitting Systolic Blood Pressure (the top number) greater than or equal to 200 mmHg and/or Mean Sitting Diastolic Blood Pressure greater than or equal to 120 mmHg Transient ischemic attack (ministroke), myocardial infarction (heart attack), all types of revascularization procedures in the last 6 months Treatment with valsartan or any combination antihypertensive treatment with 28 days prior to screening (Visit 1)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>adults</keyword>
	<keyword>Valsartan + Amlodipine</keyword>
	<keyword>Angiotensin Receptor Blockers</keyword>
</DOC>